Exact Sciences Corporation clinical trials

Acquired by Abbott, Mar 23, 2026 · source ↗

The registry lists 31 studies whose lead sponsor is Exact Sciences Corporation. 2 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 5, 2026.

Studies

Recruiting first, then most recently updated. Showing 31 of 31. All Abbott studies →

• Falcon Real World Evidence RegistryRecruitingNCT06589310

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)RecruitingNCT06401421

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Endometrial Cancer Vaginal Fluid Specimen Collection StudyActive, not recruitingNCT07544680

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted after Exact Sciences Corporation became part of Abbott

• CORRECT Study of Minimal Residual Disease Detection in Colorectal CancerActive, not recruitingNCT05210283

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Informed Choice - CompassTerminatedNCT05246839

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased RiskActive, not recruitingNCT05064553

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and MortalityActive, not recruitingNCT04124406

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal CancerActive, not recruitingNCT06398743

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act FastCompletedNCT03789162

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK TestingCompletedNCT04213326

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Home Usability Study of the SARS-CoV-2 (COVID-19) TestCompletedNCT04395391

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: "Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C"CompletedNCT04144751

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"CompletedNCT04144738

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid TumorsCompletedNCT03662204

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Stool Collection Sub-Study of Exact Sciences Protocol 2018-01CompletedNCT04473625

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act NowCompletedNCT03728348

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.CompletedNCT03741166

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood Sample Collection in Subjects Participating in a Lung Cancer Screening ProgramCompletedNCT03628638

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung CancerCompletedNCT03633006

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated MelanomaTerminatedNCT03727087

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic MalignanciesTerminatedNCT03727009

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood Sample Collection to Evaluate Biomarkers for Hepatocellular CarcinomaCompletedNCT03628651

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Blood and Stool Sample Collection in Subjects Participating in Colorectal Cancer Screening: Act BoldCompletedNCT03821948

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Observational Study of Sub-populations From Cologuard Post-Approval Study (2014-01)TerminatedNCT03705013

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test IntervalCompletedNCT02419716

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract CancersTerminatedNCT02503631

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel DiseaseCompletedNCT01819766

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)CompletedNCT02503696

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and CancerCompletedNCT01397747

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development StudiesCompletedNCT01260168

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott

• Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation TestingCompletedNCT01600209

  Sponsor listed in the registry: Exact Sciences Corporation · First submitted before Exact Sciences Corporation became part of Abbott